Progressive neuropathy as a manifestation of eosinophilic granulomatosis with polyangiitis
T. V. Balandina,
E. S. Lapina,
Yu. V. Trinitatskij,
I. Yu. Trinitatskij,
E. Yu. Komarceva,
A. V. Svechnikov https://doi.org/10.21886/2712-8156-2025-6-3-112-118
Abstract
Eosinophilic granulomatosis with polyangiitis is a rare pathology in the population with polymorphic clinical symptoms and a long history, which makes it difficult to diagnose. The presented clinical case demonstrates the importance of a multidisciplinary approach in the diagnosis of the disease and the high effectiveness of immunosuppressive therapy in relation to all manifestations of the pathology.
Keywords
eosinophilic granulomatosis with polyangiitis,
Charge-Strauss syndrome,
polyneuropathy,
eosinophilia
Supporting agencies: The study had no sponsorship support
About the Authors
T. V. Balandina
Rostov Regional Clinical Hospital
Russian Federation
Russian Federation
Tatiana V. Balandina, neurologist
Neurological Department
Rostov-on-Don
E. S. Lapina
Rostov Regional Clinical Hospital; Rostov State Medical University
Russian Federation
Russian Federation
Ekaterina S. Lapina, PhD, hematologist, assistant
Hematology Department; Department of Internal Medicine No. 1
Rostov-on-Don
Yu. V. Trinitatskij
Rostov Regional Clinical Hospital
Russian Federation
Russian Federation
Yuriy V. Trinitatsky, MD, Professor, Director of the Center
Neurology Center
Rostov-on-Don
I. Yu. Trinitatskij
Rostov Regional Clinical Hospital
Russian Federation
Russian Federation
Ivan Yu. Trinitatsky, PhD, Head of the Department
Neurological Department
Rostov-on-Don
E. Yu. Komarceva
Rostov Regional Clinical Hospital
Russian Federation
Russian Federation
Elena Yu. Komartseva, Head of the Department
Hematology Department
Rostov-on-Don
A. V. Svechnikov
Rostov Regional Clinical Hospital
Russian Federation
Russian Federation
Alexander V. Svechnikov, rheumatologist
Consultative Polyclinic
Rostov-on-Don
References
1. Zakharova E.V. ANCA-associated and cryoglobulinemic vasculitis: diagnostics and treatment. Nephrology and dialysis. 2005;7(1):6-25. (In Russ.) eLIBRARY ID: 9285684 EDN: HVFEEX
2. Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65(1):270-281. DOI: 10.1002/art.37721
3. Novikov P.I., Zhabina E.S., Fedorov K.E., Moiseev S.V. Ehozinofil’nyi granulematoz s poliangiitom (ChergA–Strauss): sovremennye vozmozhnosti diagnostiki i lecheniya. Farmateka. 2014;(15):10-18. (In Russ.) eLIBRARY ID: 22374667 EDN: SVQGFD
4. Adasheva T.V., Nesterenko O.I., Zadionchenko V.S., Harkova M.S., Samorukova E.I. Clinical case Churg-Strauss syndrome: difficulties in the diagnosis, therapeutic tactics. The Russian Archives of Internal Medicine. 2016;6(5):63-69. (In Russ.) DOI: 10.20514/2226-6704-2016-6-5-63-69
5. Cohen P, Pagnoux C, Mahr A, Arène JP, Mouthon L, Le Guern V, et al. Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum. 2007;57(4):686-693. DOI: 10.1002/art.22679
6. Sablé-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005;143(9):632-638. DOI: 10.7326/0003-4819-143-9-200511010-00006
7. Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis. 2013;72(6):1011-1017. DOI: 10.1136/annrheumdis-2012-201531
8. Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005;52(9):2926-2935. DOI: 10.1002/art.21250
9. Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Lauque D, et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum. 2008;58(2):586-594. DOI: 10.1002/art.23198
10. Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore). 2009;88(4):236-243. DOI: 10.1097/MD.0b013e3181af35a5
11. Keogh KA, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med. 2003;115(4):284-290. DOI: 10.1016/s0002-9343(03)00359-0
12. Koike H, Nishi R, Ohyama K, Morozumi S, Kawagashira Y, Furukawa S, et al. ANCA-Associated Vasculitic Neuropathies : A Review. Neurol Ther. 2022;11(1):21-38. DOI: 10.1007/s40120-021-00315-7
13. Gioffredi A, Maritati F, Oliva E, Buzio C. Eosinophilic granulomatosis with polyangiitis : an overview. Front Immunol. 2014;5:549. DOI: 10.3389/fimmu.2014.00549
14. Moiseev S.V., Semenkova E.N., Novikov P.I. Сurrent classification of systemic vasculitidеs: recommendations of International consensus conference (Chapel Hill 2012). Clinical Nephrology. 2012;2:41–46. (In Russ.)
15. Beketova T.V. New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis. Rheumatology Science and Practice. 2023;61(5):531-536. (In Russ.) DOI: 10.47360/1995-4484-2023-531-536
Review
For citations:
Balandina T.V., Lapina E.S., Trinitatskij Yu.V., Trinitatskij I.Yu., Komarceva E.Yu., Svechnikov A.V. Progressive neuropathy as a manifestation of eosinophilic granulomatosis with polyangiitis. South Russian Journal of Therapeutic Practice. 2025;6(3):112-118. (In Russ.) https://doi.org/10.21886/2712-8156-2025-6-3-112-118
Views:
47
Email this article 